A dipeptidyl peptidase (DPP)-4 inhibitor accelerated breast cancer metastasis by inducing EMT through CXCL12/CXCR4/mTOR axis, while metformin countered the harmful effect of DPP-4 inhibitor on breast cancer metastasis 72. Here, DPP4 is linked to breast cancer.